1,624
Views
10
CrossRef citations to date
0
Altmetric
Drug Profile

JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials

&
Pages 701-715 | Received 28 Feb 2021, Accepted 30 Apr 2021, Published online: 13 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jürgen Braun, Uta Kiltz & Xenofon Baraliakos. (2022) Management of Axial Spondyloarthritis – Insights into Upadacitinib. Drug Design, Development and Therapy 16, pages 3609-3620.
Read now
Ennio Lubrano, Michele Maria Luchetti, Devis Benfaremo, Daniele Mauro, Francesco Ciccia & Fabio Massimo Perrotta. (2021) Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician. Expert Review of Clinical Immunology 17:11, pages 1199-1209.
Read now

Articles from other publishers (8)

M. Gasparotto, C. Franco, E. Zanatta, A. Ghirardello, M. Zen, L. Iaccarino, B. Fabris, A. Doria & M. Gatto. (2023) The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review. Autoimmunity Reviews 22:6, pages 103334.
Crossref
Qian He, Jia-qi Chen, Xin-bo Yu, Jia-he Liao, Zi-wei Huang, Jian-ying Yang, Tzu-Hua Wu, Wei-jiang Song, Jing Luo & Qing-wen Tao. (2023) Knowledge mapping of biological disease-modifying anti-rheumatic drugs for axial spondyloarthritis: a bibliometric study. Clinical Rheumatology.
Crossref
Saviana Gandolfo & Francesco Ciccia. (2022) JAK/STAT pathway targeting in primary Sjögren syndrome. Rheumatology and Immunology Research 3:3, pages 95-102.
Crossref
Evgeny L. Nasonov. (2022) Janus kinase inhibitors in immunoinflammatory rheumatic diseases. Terapevticheskii arkhiv 94:5, pages 605-609.
Crossref
E. L. Nasonov & T. V. Korotaeva. (2022) Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology. Rheumatology Science and Practice 60:2, pages 131-148.
Crossref
Yihao Li, Dan Meng, Jiali Xie, Ruoyu Li, Zifan Wang, Jinlong Li, Lin Mou, Xinhao Deng & Ping Deng. (2022) Design of Rational JAK3 Inhibitors Based on the Parent Core Structure of 1,7-Dihydro-Dipyrrolo [2,3-b:3′,2′-e] Pyridine. International Journal of Molecular Sciences 23:10, pages 5437.
Crossref
Yoshiya Tanaka, Yiming Luo, John J. O’Shea & Shingo Nakayamada. (2022) Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nature Reviews Rheumatology 18:3, pages 133-145.
Crossref
Bin Wang, Shiju Chen, Yan Li, Jingxiu Xuan, Yuan Liu & Guixiu Shi. (2021) Targeted Therapy for Primary Sjögren’s Syndrome: Where are We Now?. BioDrugs 35:6, pages 593-610.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.